In episode 26 the pharmaphorum podcast hears from David Solomon, a 30-year life sciences industry veteran who recently took up the position of CEO at the Paris-based biopharmaceutical company Pharnext.
Digital therapeutics at a turning point: What we heard at DtX East
Understanding and addressing care disparities in rare cancers
Turning drug development on its head
GLP-1 Weight loss drugs: An overview and update
Biopharma’s rapid transition to omnichannel marketing
Partnering for holistic care
Mapping the landscape of clinical trial regulation
Preparing for the tsunami of healthcare data approaching
Alzheimer’s drugs: An overview and update
Suffering beyond physical effects: inequalities and taboos in prostate cancer
Collaborative perseverance to bring change to medicine access
Botanicals in pharma: Potential and pitfalls
Clinical trial diversity: An update
Changing personnel dynamics in the pharma world
Retaining the human quality of healthcare in DTx
Focusing on predictability and execution in digital trials
Genetic testing update with 23andMe’s Noura Abul-Husn
Headlines and hot topics from ASCO and BIO
The precision element at the heart of digital transformation
AI in drug development: A reality check
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Stuff To Blow Your Mind
Unexplainable
Speaking of Psychology